Načítá se...
Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension
Sildenafil is a phosphodiesterase type-5 inhibitor approved for treatment of pulmonary arterial hypertension (PAH) in adults. Data from pediatric trials demonstrate a similar acute safety profile to the adult population but have raised concerns regarding the safety of long-term use in children. Inte...
Uloženo v:
| Vydáno v: | Drug Healthc Patient Saf |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687613/ https://ncbi.nlm.nih.gov/pubmed/26719728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S65571 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|